Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemPoint Capital
New York, New York, United Statesstempointcapital.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
StemPoint Capital is a New York-based, long-biased equity asset management and hedge fund firm dedicated to the global life sciences industry. Founded in 2023 by Michelle Ross, it specializes in investing across the biotechnology and pharmaceutical sectors using a fundamental, science-driven research process. The firm manages hundreds of millions of dollars in assets and seeks to generate absolute returns by leveraging growth opportunities in biotech and defensive qualities of pharma. It invests primarily in public companies at various stages, with particular focus on biopharma innovation[1][3][6].
- Therapeutic areas
- Other
- Modalities
- Not applicable (investment firm; does not develop therapeutics directly)
- Industry
- Investors
02
Partnerships
Leucadia Asset Management (minority economic interest/strategic relationship)[6]
Beyond the preview
Go deeper on StemPoint Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StemPoint Capital.